AUS
NZ
UK
CA
USA
IND
Healt
ResMed (ASX:RMD) Share Price Outlook: Exploring Healthcare Opportunities in the ASX 200
August 21, 2025 11:33 AM AEST| By Team Kalkine MediaHighlights,ResMed (RMD) focuses on medical devices and SaaS healthcare solutions,Healthcare sector known for consistent revenue streams,Global demand for healthcare technology continues to expand,Healthcare companies often stand out among,ASX 200 com...
Tryp Advances Precision Psychiatry with Exclusive EEG-Based Biomarker Agreement
August 21, 2025 11:05 AM AEST| By Team Kalkine MediaHighlights,Tryp enters exclusive agreement to develop EEG biomarker,Biomarker aims to enhance therapeutic outcomes for TRP-8803,Collaboration integrates neuroscience with real-time data analysis,Tryptamine Therapeutics Ltd (ASX:TYP) has taken a major...
Lumos Diagnostics ASX:LDX CLIA Waiver Progress Strengthens Position in ASX 200 Index
August 20, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics (ASX:LDX) advanced its regulatory pathway with a CLIA waiver submission for FebriDx in the United States.,The company secured milestone and prepayment inflows linked to the regulatory filing and partnership agreements.,Br...
Lumos Diagnostics Advances FebriDx Pathway with FDA Waiver Bid
August 20, 2025 04:09 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics submits CLIA waiver application for FebriDx.,Broader US market access anticipated upon approval.,Strategic focus on reimbursement support and adoption.,Lumos Diagnostics (ASX:LDX) has taken a significant step forward with...
CSL Shares Impact asx 200 After Mixed Fiscal Update
August 20, 2025 03:08 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) shares moved lower after reporting a mixed yearly outcome,Revenue and earnings fell short of consensus while net profit aligned with company guidance,Company announced restructuring with workforce adjustments and strategic ch...
ASX Higher Despite CSL Shares Falling and James Hardie Nosedive – Australian Share Market Today
August 20, 2025 02:30 PM AEST| By Team Kalkine MediaHighlights,Major banks and financial stocks led the upward movement in the Australian share market.,CSL (ASX:CSL) experienced a second day of decline following its reporting season results.,James Hardie (ASX:JHX) shares dropped amid a profit slump.,T...
Insider Ownership Drives Confidence in Mesoblast Limited (ASX:MSB)
August 20, 2025 11:48 AM AEST| By Team Kalkine MediaHighlights,Insider ownership holds strong influence in Mesoblast Limited,Institutions show notable interest in the company’s position,General public remains a significant part of the shareholder base,The dynamics of shareholder structures often play...
CSL (ASX:CSL) Shake-Up Sends Ripples Across ASX 200
August 20, 2025 10:26 AM AEST| By Team Kalkine MediaHighlights,CSL (CSL) share price experiences sharp decline,Transformation plan and restructuring raise concerns,Broader ASX 200 index also feels the impact,CSL Limited (ASX:CSL), one of the leading,ASX 200 companies,, recently surprised the market wi...
CSL Restructure Overshadows Profit Growth Among ASX 200 Companies
August 19, 2025 06:37 PM AEST| By Team Kalkine MediaHighlights,CSL reports stronger earnings performance,Major restructuring with global workforce changes,Seqirus vaccine unit set for demerger,CSL Limited (ASX:CSL), one of the leading,ASX 200 companies,, reported robust annual results, showing growth...
Pro Medicus (ASX:PME) in Spotlight: Key Metrics Driving ASX 200 Healthcare Tech Growth
August 19, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus (PME) provides advanced radiology IT solutions globally,Strong financial position with consistent revenue and profit growth,Innovative Visage software enhances diagnostic efficiency,Pro Medicus (ASX:PME), a well-known name amon...
EVE Health Group Moves Closer to Market Launch with First Order for Libbo
August 19, 2025 03:54 PM AEST| By Team Kalkine MediaHighlights,EVE Health Group progresses with first order for Libbo.,Treatment aims to provide patient-friendly solution for ED.,Manufacturing underway with launch preparations in motion.,EVE Health Group (ASX:EVE) has taken a significant step forward...
Argent BioPharma Boosts Pipeline with Strategic Acquisition
August 19, 2025 03:41 PM AEST| By Team Kalkine MediaHighlights,Argent BioPharma (RGT) to acquire key clinical and IP assets from AusCann (AC8).,Deal adds Neuvis technology, EU manufacturing, and distribution channels.,Integration set to support global expansion and clinical readiness.,Argent BioPharma...
S&P 200 Lumos Diagnostics and Biotech Advances in Respiratory Care
August 19, 2025 03:22 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics (ASX:LDX) develops FebriDx to distinguish bacterial and viral respiratory infections,Respiratory illnesses remain a leading health burden worldwide with increasing antimicrobial resistance,Biotech sector innovations inclu...
S&P/ASX 200 CSL Shares Drop as Biotech Flags Job Cuts and Flu Spin-off
August 19, 2025 02:26 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) announces restructuring of influenza vaccine business,Significant workforce reductions are planned alongside the spin-off,ASX 200 faces a downward trend following the company’s updates,The biotechnology sector on the ASX expe...
S&P 200 Updates CSL Shares Record One-Day Drop Amid Biotech Restructure
August 19, 2025 02:25 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) experiences significant decline following corporate restructure and strategic announcements.,BHP (ASX:BHP) signals challenges in the Australian economic landscape impacting outlook.,Reliance Worldwide (ASX:RWC), HMC Capital (...
ASX 200 Today CSL Shares Face Volatility Amid Mixed Biotech Results
August 19, 2025 02:14 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) reports mixed fiscal year results impacting share performance.,Restructuring plans include staffing reductions and a share buy-back program.,Revenue and underlying EBIT fall short of consensus, while NPATA remains aligned wit...
Lumos Diagnostics Advances FebriDx with FDA Waiver Application Amid ASX 200 Stocks Momentum
August 18, 2025 11:05 AM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics submits CLIA waiver application for FebriDx,Clinical study supports ease of use for broader access,Partnership set to strengthen US market adoption,Lumos Diagnostics (ASX:LDX) has taken a major step forward by submitting...
Strategic Alliance Brings FebriDx® to the Forefront of U.S. Healthcare
August 14, 2025 07:52 PM AEST| By Team Kalkine MediaHighlights,Strategic alliance accelerates FebriDx® adoption across U.S. healthcare.,PRO-spectus provides comprehensive support for reimbursement and market access.,Effort aims to improve diagnosis and curb unnecessary antibiotic use.,Lumos Diagnostic...
ASX200 Pro Medicus (ASX:PME) Records Strong FY2025 Growth and Expands Global Reach
August 14, 2025 05:56 PM AEST| By Team Kalkine MediaHighlights,Achieved record revenue in FY2025,Strong US market contracts drive performance,Margins reached highest level to date,Pro Medicus posted record-breaking results for FY2025, reinforcing its position as one of the notable performers within th...
ASX 200 Healthcare Stock Gains Attention in S&P/ASX Indices
August 14, 2025 05:04 PM AEST| By Team Kalkine MediaHighlights,Neuren Pharmaceuticals (ASX:NEU) operates in the biotechnology sector with a focus on central nervous system conditions,Lead therapy Daybue, licensed to Acadia (NASDAQ:ACAD), records continued growth in the US market,Preparations underway...
Advertise your brand on Kalkine Media